Latest Medical Technology from Bio-Medicine.Org

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 07:50:48 MST

BOTHELL, Wash., Nov. 6 /- SCOLR Pharma, Inc. (Amex: DDD ) today reported financial results for the three and nine months ended September 30, 2009. Stephen J. Turner, SCOLR Pharma's President and CEO, said, "We continue to advance discussions related to licensing our 12-hour ibuprofen formulation. Several potential partners have committed significant resource...

Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009

Fri, 06 Nov 2009 04:07:52 MST

DURHAM, N.C., Nov. 6 /- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a previously approved reverse split of its common stock will take effect at the start of trading on Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted basis. Oxygen Biotherapeutics, Inc. shares will trade under the new symbol OXBT. The stock also will have a new CUSIP...

Recession Continues to Depress Sales at Allied Healthcare Products

Fri, 06 Nov 2009 04:07:47 MST

ST. LOUIS, Nov. 6 /- Recession in domestic and international markets continued to depress sales for Allied Healthcare Products in the first quarter of fiscal year 2010 ending September 30, 2009. Sales declines pushed Allied into a loss for the quarter. The net loss for the quarter was about $745,000, or negative 9 cents per share, compared to a net profit the...

McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP

Fri, 06 Nov 2009 04:07:39 MST

FORT WASHINGTON, Pa., Nov. 6 /- In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating a voluntary recall of a limited number of product lots of TYLENOL® Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP. McNeil is initiating the recall after identifyin...

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

Fri, 06 Nov 2009 04:07:36 MST

WILMINGTON, Mass., Nov. 6 /- DUSA Pharmaceuticals, Inc.(®) (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan(®) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Merriman Curha...

Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering

Fri, 06 Nov 2009 04:07:33 MST

SAN DIEGO, Nov. 6 /- Trius Therapeutics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company. Credit Suisse Securities (USA) LL...

Watson to Present at Credit Suisse Healthcare Conference

Fri, 06 Nov 2009 04:07:30 MST

MORRISTOWN, N.J., Nov. 6 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern St...

Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results

Fri, 06 Nov 2009 04:07:27 MST

OAKLAND, Calif., Nov. 6 /- Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (KFHP/H), and their subsidiaries reported today a combined total operating revenue of $10.5 billion for the quarter ended September 30, 2009, compared to $10.2 billion in the third quarter of last year. Operating income in the third quarter was $336 million, compared to $307 million in...

NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009

Fri, 06 Nov 2009 01:28:15 MST

WESTBURY, N.Y., Nov. 6 /- Repossessions and liquidations of trucking equipment and machine tools in the third quarter of 2009 declined as compared to similar figures from 2008, according to Nassau Asset Management's NasTrac Quarterly Index (NQI). The figures, culled from the company's activity reports for both repossessions and orderly liquidations, also indicated a rise in r...

Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses

Fri, 06 Nov 2009 01:28:05 MST

SARASOTA, Fla., Nov. 6 /- Roper Industries, Inc. (NYSE: ROP) today announced that it has signed a definitive agreement to acquire Verathon, Inc., a leading provider of proprietary medical devices. The Verathon Board of Directors has approved the transaction and the closing is subject to customary regulatory approvals and closing conditions, including shareholder...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution

Fri, 06 Nov 2009 01:27:52 MST

DETROIT, Nov. 6 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic Acular® ophthalmic solution on the first day following patent expiration. This s...

Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession

Fri, 06 Nov 2009 01:27:48 MST

CHARLESTON, S.C., Nov. 6 /PRNewswire-USNewswire/ -- The 'Help is Here Express' bus tour will be stopping in South Carolina and Georgia throughout the week of November 9-13 at various cities in order to help uninsured and financially-struggling patients access information on programs that provide prescription medicines for free or nearly free. With the nation's unemployment rate now hitti...

Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962)

Fri, 06 Nov 2009 01:27:41 MST

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- America's Specialty Medicines Companies (ASMC), an informal working group of mid-market and smaller innovator pharmaceutical companies, today expressed concerns about H.R. 3962, the "Affordable Health Care for America Act," introduced by House Democrats last Thursday. These smaller companies fear that the cumulative effect of a host of provisi...

Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call

Fri, 06 Nov 2009 08:17:59 MST

PRINCETON, N.J., Nov. 6 /- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its third quarter 2009 results before market on Monday, November 16, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call (866) 788-0546 (do...

Facet Solutions Acquires Archus Orthopedics

Fri, 06 Nov 2009 08:17:54 MST

HOPKINTON, Mass., Nov. 6 /- Facet Solutions, Inc. announced today that it has acquired all of the assets of Archus Orthopedics. The acquisition creates an undisputed leadership position in product offerings, intellectual property and clinical experience in posterior motion preservation. "This is a win for patients suffering from lumbar spinal stenosis," stated Facet Solutions'...

NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates

Fri, 06 Nov 2009 08:17:49 MST

SAN DIEGO, Nov. 6 /- NuVasive, Inc. (Nasdaq: NUVA ), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today the appointment of Michael J. Lambert as Executive Vice President and Chief Financial Officer, effective November 9, 2009. The Company also announced several other Executive Manageme...

Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant

Fri, 06 Nov 2009 08:17:42 MST

NATICK, Mass., Nov. 6 /- Boston Scientific Corporation (NYSE: BSX ) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant. Boston Scien...

OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy

Fri, 06 Nov 2009 08:17:25 MST

LEXINGTON, Ky., Nov. 6 /- Virtual Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed today that the previously confirmed Letter of Intent to sell all health care related assets to Wound Management Technologies, Inc (WNDM) is subject to final approval of the Board of Directors and shareholders of VHGI. Shareholder Assurances "We believe th...

Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation

Fri, 06 Nov 2009 08:17:19 MST

MURRYSVILLE, Pa., Nov. 6 /- Philips Respironics applauds the efforts of the Centers for Disease Control and Prevention (CDC) to raise awareness about an important public health issue -- chronic sleep insufficiency. The CDC's release of the first-ever government study to monitor state-by-state differences in sleeplessness is a milestone in quantifying the size and scope of the...

Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole'

Fri, 06 Nov 2009 08:17:02 MST

WINNIPEG, Manitoba, Nov. 6 /- With his proposed health care reform plan, President Barack Obama has set his sights on cutting name-brand prescription drug costs by 50 percent for Medicare patients who fall into the "Part D" coverage gap, universally known as the "donut hole." Plan advocates rave about the potential cost-cutting and feel it's a promising start to health care re...